Loading patent…
AssigneeMagic Epoch Holdings Limited
InventorsJari Koistinaho, Tarja Malm, Eveliina Pollari, Katja Kanninen
Estimating the term…
The present invention relates to the fields of life sciences and medicine. Specifically, the invention relates to therapies of neurodegenerative diseases. More specifically, the present invention relates to interleukin-33 (IL-33), a fragment thereof, a polynucleotide encoding IL-33 or a fragment thereof for use in treatment or prevention of a neurodegenerative disease involving inflammation in a subject and to a method of treating or preventing a neurodegenerative disease involving neuroinflammation in a subject. Still, the present invention relates to IL-33, a fragment thereof, a polynucleotide encoding IL-33 or a fragment thereof for use in improving or restoring neuronal function or endogenous neuronal repair mechanisms, or enhancing endogenous neurogenesis, oligodendrogenesis or neuronal differentiation in a subject. Also, the present invention relates to a method of improving or restoring neuronal function or endogenous neuronal repair mechanisms, or enhancing endogenous neurogenesis, oligodendrogenesis or neuronal differentiation in a subject.
A method of treating a neurodegenerative disease involving neuroinflammation in a subject, wherein the method comprises administration of IL-33 to the subject, wherein the neurodegenerative disease involving neuroinflammation is selected from the group consisting of tauopathies, Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), spinal cord injury (SCI), and neuronal ceroid lipofuscinoses (NCL).
A method for improving or restoring neuronal function or endogenous neuronal repair mechanisms, or for enhancing endogenous neurogenesis, oligodendrogenesis, or neuronal differentiation:
A method for improving or restoring neuronal function or endogenous neuronal repair mechanisms, or for enhancing endogenous neurogenesis, oligodendrogenesis, or neuronal differentiation:
Dependencies are inferred from the claim text.